Treatment strategies in acute myeloid leukemia |
| |
Authors: | Han Li-na Zhou Jin Schuringa Jan Jacob Vellenga Edo |
| |
Affiliation: | Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. |
| |
Abstract: | Objective To summarize the risk stratification and current treatment strategies for acute myeloid leukemia (AML) and discuss the role of emerging novel agents that might be applied in future clinical trials.Data sources The data in this article were collected from PubMed database with relevant English articles published from 1991 to 2009.Study selection Articles regarding the risk stratification and therapeutic options of AML, as well as the characteristics of leukemic stem cells were selected.Results AML is a heterogeneous disease with variable clinical outcome dependent on several prognostic factors,including age, cytogenetics and molecular markers. The advances in the understanding of AML pathogenesis and development will generate potential novel agents that might improve the treatment results of standard chemotherapy.Conclusion Deeper insight into the multiple transforming events of AML may aid us in designing combinations of small molecule inhibitors based on the individual patient characteristics. |
| |
Keywords: | acute myeloid leukemia leukemic stem cell treatment novel agents |
本文献已被 维普 万方数据 PubMed 等数据库收录! |
| 点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息 |
|
点击此处可从《中华医学杂志(英文版)》下载全文 |